인쇄하기
취소

Boryung Pharm wins Korea patent for novel antihypertensive formulation

Published: 2004-08-12 06:56:00
Updated: 2004-08-12 06:56:00
Boryung announced recently it have obtained a Korean patent relating to pyrimidinone compound, pharmaceutical composition containing it and its manufacturing method.

According to the novel process patent, the novel antihypertensive compound (codename: BRA-657) has an antagonizing action against angiotensin II receptor associated with the increase of hypertension and electrolyte levels in th...

Fees

- Email service daily and homepage access.
  1. $300 per month.
  2. 5 Email holders per each company.
  3. Anual contract base.
Copyright Yakup.com All rights reserved.
약업닷컴의 모든 컨텐츠는 저작권법의 보호를 받습니다. 무단 전재⋅복사⋅배포 등을 금합니다.